Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Fitzgerald

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|August 3, 1999
Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometryR L Fitzgerald, J D Rivera, D A Herold
International Review of Neurobiology|October 16, 2001
Neurosteroid analysisA A Alomary, R L Fitzgerald, R H Purdy
Clinical Chemistry|March 1, 1994
Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometryR L Fitzgerald, D A Rexin, D A Herold
Critical Reviews in Clinical Laboratory Sciences|April 1, 1996
Current techniques in mycobacterial detection and speciationC D Herold, R L Fitzgerald, D A Herold
Pediatric Dermatology|March 1, 1997
CTCL in patients under 20 years of age: a series of five casesP R Hickham, E I McBurney, R L Fitzgerald
American Journal of Clinical Pathology|March 1, 1997
Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometryT Nishikawa, H Ohtani, D A Herold, et al.
The Journal of Biological Chemistry|July 13, 2000
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglyceridesZ Chen, R L Fitzgerald, M R Averna, et al.
Critical Reviews in Clinical Laboratory Sciences|January 1, 1994
Mass spectrometry of trace elements in biological samplesS K Aggarwal, M Kinter, R L Fitzgerald, et al.
Journal of Analytical Toxicology|September 1, 1988
Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalersR L Fitzgerald, J M Ramos, S C Bogema, et al.
Forensic Science International|April 1, 1993
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA)A Poklis, R L Fitzgerald, K V Hall, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|August 3, 1999
Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometryR L Fitzgerald, J D Rivera, D A Herold
International Review of Neurobiology|October 16, 2001
Neurosteroid analysisA A Alomary, R L Fitzgerald, R H Purdy
Clinical Chemistry|March 1, 1994
Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometryR L Fitzgerald, D A Rexin, D A Herold
Critical Reviews in Clinical Laboratory Sciences|April 1, 1996
Current techniques in mycobacterial detection and speciationC D Herold, R L Fitzgerald, D A Herold
Pediatric Dermatology|March 1, 1997
CTCL in patients under 20 years of age: a series of five casesP R Hickham, E I McBurney, R L Fitzgerald
American Journal of Clinical Pathology|March 1, 1997
Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometryT Nishikawa, H Ohtani, D A Herold, et al.
The Journal of Biological Chemistry|July 13, 2000
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglyceridesZ Chen, R L Fitzgerald, M R Averna, et al.
Critical Reviews in Clinical Laboratory Sciences|January 1, 1994
Mass spectrometry of trace elements in biological samplesS K Aggarwal, M Kinter, R L Fitzgerald, et al.
Journal of Analytical Toxicology|September 1, 1988
Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalersR L Fitzgerald, J M Ramos, S C Bogema, et al.
Forensic Science International|April 1, 1993
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA)A Poklis, R L Fitzgerald, K V Hall, et al.
Pageof 4